COMPOSITION ET FORMULATION LIPIDIQUE D'UNE ENZYME DÉGRADANT LE HYALURONANE ET SON UTILISATION POUR LE TRAITEMENT DE L'HYPERPLASIE BÉNIGNE DE LA PROSTATE
Provided are compositions and formulations or co-formulations containing a hyaluronan degrading enzyme. The compositions, formulations or co-formulations can also contain another therapeutic agent, such as one that is suitable for treatment of Benign Prostatic Hyperplasia, for example, a 5-alpha reductase inhibitor. The compositions and formulations can be used for the treatment of Benign Prostatic Hyperplasia. The compositions and formulations can be provided in combinations with one or more other agents for the treatment of Benign Prostatic Hyperplasia.